Literature DB >> 27814841

Industry Funding of Cancer Patient Advocacy Organizations.

Matthew V Abola1, Vinay Prasad2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27814841     DOI： 10.1016/j.mayocp.2016.08.015

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  Examining Physician Interactions with Disease Advocacy Organizations.

Authors:  Caroline Horrow; Joel E Pacyna; Carol Cosenza; Richard R Sharp
Journal:  AJOB Empir Bioeth       Date:  2019-08-26

2.  Cancer treatments should benefit patients: a common-sense revolution in oncology.

Authors:  Bishal Gyawali; Christopher M Booth
Journal:  Nat Med       Date:  2022-04       Impact factor: 87.241

3.  Financial relationships between patient and consumer representatives and the health industry: A systematic review.

Authors:  Joanne Khabsa; Aline Semaan; Amena El-Harakeh; Assem M Khamis; Serena Obeid; Hussein A Noureldine; Elie A Akl
Journal:  Health Expect       Date:  2019-12-19       Impact factor: 3.377

4.  When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.

Authors:  Orna Ehrlich; Laura Wingate; Caren Heller; Inmaculada de Melo-Martin
Journal:  BMC Med Ethics       Date:  2019-12-17       Impact factor: 2.652

5.  Industry funding of patient and health consumer organisations: systematic review with meta-analysis.

Authors:  Alice Fabbri; Lisa Parker; Cinzia Colombo; Paola Mosconi; Giussy Barbara; Maria Pina Frattaruolo; Edith Lau; Cynthia M Kroeger; Carole Lunny; Douglas M Salzwedel; Barbara Mintzes
Journal:  BMJ       Date:  2020-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.